Question

In pediatric patients receiving cyclophosphamide for autoimmune disease, a significant risk of permanent azoospermia is associated with a cumulative dose above:

• A. 100 mg/kg
• B. 250 mg/kg
• C. 500 mg/kg
• D. 1000 mg/kg

Hint:

Cumulative threshold for high risk of cyclophosphamide-induced permanent infertility: $>250\text{ mg/kg}$ (or $>7.5\text{ g/m}^2$). Leydig cells are relatively resistant compared to germ cells, so testosterone levels typically remain normal.

Answer 1

The Correct Option is B

Concept:
Cyclophosphamide is a potent alkylating agent used in the induction therapy of severe, life-threatening pediatric autoimmune conditions, such as proliferative lupus nephritis and systemic vasculitis.
Gonadotoxicity is one of its most critical long-term dose-limiting adverse effects, causing destruction of rapidly dividing germ cells (spermatogonia) in males and depletion of primordial ovarian follicles in females.
Explanation:
• Alkylating agents cause cross-linking of DNA, which selectively damages actively proliferating spermatogonia in the testicular seminiferous tubules, leading to oligospermia or irreversible azoospermia.

• In pediatric and adolescent males, the risk of permanent gonadal damage is directly correlated with the cumulative lifetime dose administered.

• A cumulative dose exceeding $250\text{ mg/kg}$ (or approximately $>7.5$--$10\text{ g/m}^2$) carries a substantially increased and significant risk of permanent germ cell failure and permanent azoospermia.

• Doses below $150$--$200\text{ mg/kg}$ generally have a lower risk of permanent infertility, with potential for recovery of spermatogenesis years after cessation of therapy.

• To minimize this risk in pediatric rheumatology, intravenous pulse cyclophosphamide regimens or alternative immunosuppressive agents like mycophenolate mofetil (MMF) or rituximab are preferred over prolonged daily oral cyclophosphamide.
Final Answer:
A cumulative cyclophosphamide dose above $250\text{ mg/kg}$ is associated with a significant risk of permanent azoospermia in male pediatric patients.